1. Home
  2. SDGR vs MRVI Comparison

SDGR vs MRVI Comparison

Compare SDGR & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SDGR

Schrodinger Inc.

HOLD

Current Price

$17.99

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$5.60

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDGR
MRVI
Founded
1990
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
SDGR
MRVI
Price
$17.99
$5.60
Analyst Decision
Buy
Buy
Analyst Count
9
4
Target Price
$21.00
$4.13
AVG Volume (30 Days)
1.1M
2.2M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
45.14
14.29
EPS
N/A
N/A
Revenue
$255,869,000.00
$185,743,000.00
Revenue This Year
$0.76
$12.54
Revenue Next Year
$4.60
$7.87
P/E Ratio
N/A
N/A
Revenue Growth
23.29
N/A
52 Week Low
$10.95
$2.29
52 Week High
$23.02
$7.44

Technical Indicators

Market Signals
Indicator
SDGR
MRVI
Relative Strength Index (RSI) 70.19 N/A
Support Level $17.26 N/A
Resistance Level $19.51 N/A
Average True Range (ATR) 0.72 0.00
MACD 0.28 0.00
Stochastic Oscillator 80.55 0.00

Price Performance

Historical Comparison
SDGR
MRVI

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: